IO Biotech Announces New Data Related to its IO102-IO103 Therapeutic Cancer Vaccine Presented Today at the IASLC 2023 World Conference on Lung Cancer
Encouraging interim data support the potential of IO102-IO103 in combination with pembrolizumab as first-line treatment…
Vocalbeats.AI Achieves ISO/IEC 42001 Certification, Reinforcing Responsible AI Governance